RecruitingNCT07419555

Belgian Lung Function Study

Belgian Lung Function Study: Personalised Longitudinal Lung Function Analysis as a Marker of Disease Progression


Sponsor

KU Leuven

Enrollment

4,000 participants

Start Date

Mar 25, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns. A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Above 18 years old
  • Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals
  • Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline
  • Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion
  • Planned routine follow-up within standard clinical care in one of the participating hospitals

Exclusion Criteria2

  • Patients who have had a lung transplantation
  • Patients not being able to give consent to participate

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

UZ Antwerpen

Edegem, Belgium

Ziekenhuis Oost-Limburg

Genk, Belgium

UZ Leuven

Leuven, Belgium

AZ Delta

Roeselare, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07419555


Related Trials